title: Posterior reversible encephalopathy syndrome due to pulse methylprednisolone therapy in a child.
abstract: Posterior reversible leukoencephalopathy syndrome (PRES) is a recently described disorder with typical radiological findings of bilateral grey and white matter abnormalities in the posterior regions of the cerebral hemispheres. It has been described in children in association with some medications, renal disease, autoimmune disease, transplantation, and sepsis. In this report, we discuss an eight-year-old boy with PRES during pulse methylprednisolone therapy. In conclusion, PRES is a neurological complication of pulse methylprednisolone therapy, which responds favorably to prompt therapy withdrawal and blood pressure control.
authors.affiliation: Division of Pediatric Neurology, Department of Pediatrics, Çukurova University Faculty of Medicine, Adana, Turkey. fincecik@yahoo.com.
authors.forename: Faruk
authors.initials: F
authors.lastname: İncecik
authors.forename: M Özlem
authors.initials: MÖ
authors.lastname: Hergüner
authors.forename: Dinçer
authors.initials: D
authors.lastname: Yıldızdaş
authors.forename: Mustafa
authors.initials: M
authors.lastname: Yılmaz
authors.forename: Gülen
authors.initials: G
authors.lastname: Mert
authors.forename: Özden O
authors.initials: ÖO
authors.lastname: Horoz
authors.forename: Şakir
authors.initials: Ş
authors.lastname: Altunbaşak
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D002648:Child; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D005938:Glucocorticoids; D008775:Methylprednisolone